Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Pharmacoepidemiology and Drug Safety|August 21, 2013
Accuracy of International Classification of Diseases, 9th Revision, Clinical Modification codes for upper gastrointestinal complications varied by position and age: a validation study in a cohort of nonsteroidal anti-inflammatory drugs users in Friuli Venezia Giulia, ItalyFederica Pisa, Jordi Castellsague, Daniela Drigo, et al.Arthritis and Rheumatism|July 29, 2006
Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugsGeorgio Mosis, Theo Stijnen, Jordi Castellsague, et al.Pharmacoepidemiology and Drug Safety|December 12, 2012
Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, ItalyJordi Castellsague, Federica Pisa, Valentina Rosolen, et al.Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart diseaseWayne A Ray, Cristina Varas-Lorenzo, Cecilia P Chung, et al.Pharmacoepidemiology and Drug Safety|July 26, 2018
Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and GermanyJordi Castellsague, Beatriz Poblador-Plou, Maria Giner-Soriano, et al.Current Drug Safety|October 12, 2013
Validation of acute liver injury cases in a population-based cohort study of oral antimicrobial usersChristine L Bui, James A Kaye, Jordi Castellsague, et al.Pharmacotherapy|May 29, 2014
Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort studyJames A Kaye, Jordi Castellsague, Christine L Bui, et al.Drugs - Real World Outcomes|May 9, 2018
Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort StudyJosephina G Kuiper, Myrthe P P van Herk-Sukel, Jordi Castellsague, et al.Clinical Epidemiology|March 22, 2018
A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study)Jordi Castellsague, Josephina G Kuiper, Anton Pottegård, et al.Pharmacoepidemiology and Drug Safety|January 31, 2017
Characterization of new users of cilostazol in the UK, Spain, Sweden, and GermanyJordi Castellsague, Susana Perez-Gutthann, Brian Calingaert, et al.Pageof 4